Literature DB >> 28504879

Antitubercular Activity of Mycelium-Associated Ganoderma Lanostanoids.

Masahiko Isaka1, Panida Chinthanom1, Malipan Sappan1, Sumalee Supothina1, Vanicha Vichai1, Kannawat Danwisetkanjana1, Thitiya Boonpratuang1, Kevin D Hyde2, Rattaket Choeyklin3.   

Abstract

In a continuation of our research into antitubercular lanostane triterpenoids from submerged cultures of Ganoderma species, three strains, Ganoderma orbiforme BCC 22325, Ganoderma sp. BCC 60695, and Ganoderma australe BCC 22314, have been investigated. Fourteen new lanostane triterpenoids, together with 35 known compounds, were isolated. Antitubercular activities of these mycelium-associated Ganoderma lanostanoids against Mycobacterium tuberculosis H37Ra were evaluated. Taken together with the assay data of previously isolated compounds, structure-activity relationships of the antitubercular activity are proposed. Most importantly, 3β- and 15α-acetoxy groups were shown to be critical for antimycobacterial activity. The most potent compound was (24E)-3β,15α-diacetoxylanosta-7,9(11),24-trien-26-oic acid (35).

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28504879     DOI: 10.1021/acs.jnatprod.6b00973

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  2 in total

1.  Semisynthetic modifications of antitubercular lanostane triterpenoids from Ganoderma.

Authors:  Panida Chinthanom; Vanicha Vichai; Kanchana Dokladda; Malipan Sappan; Chawanee Thongpanchang; Masahiko Isaka
Journal:  J Antibiot (Tokyo)       Date:  2021-05-12       Impact factor: 2.649

2.  Antimycobacterial Activity and Safety Profile Assessment of Alpinia galanga and Tinospora cordifolia.

Authors:  Mohamed F Alajmi; Ramzi A Mothana; Adnan J Al-Rehaily; Jamal M Khaled
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-08       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.